Daily FNArena News - Australia

Treasury Wine Estates has flagged strong earnings growth for 2019, although several brokers remain concerned about the softer US wine business signalled by competitor, Constellation Brands.

NZ-based manufacturer Methven is expected to extend GWA Group’s range of bathroom & kitchen products and diversify its geographic exposure.

A merger of Australian Pharmaceutical Industries and Sigma Healthcare is logical but ACCC issues are uppermost in broker views.

Sonic Healthcare will acquire Aurora Diagnostics, which is expected to transform its US business and provide substantial revenue synergies.

Inaugural Edition of the Australian Broker Call *Extra* Edition, featuring additional expert sources on additional ASX-listed stocks. Re-published to remove technical errors.

Brokers suggest the market has overreacted to QBE’s update, given the progress made in 2018 and the cost reductions outlined for the next three years.

Is Australia’s housing market a source of vulnerability for the economy?

Delays in infrastructure activity and an uncertain housing outlook have cast a shadow over Adelaide Brighton, which has downgraded earnings estimates for 2018.

Australia’s prudential regulator has punished IOOF and investors, in turn, now punish the stock. The acquisition of the ANZ wealth business hangs in limbo.

Revenue growth in core plasma products is still expected as CSL embarks on new classes of therapy in its R&D pipeline.